Monday, September 29, 2008

Investigations: 57% of Pharma Trials Go Unpublished

The results of 57 percent of studies on new pharmaceutical drugs aren't published within five years of the drug coming to market, says this Guardian story on a review of 90 drugs approved by U.S. regulators. The researchers say the failure of drug companies to publish the evidence amounts to "scientific misconduct" and "harms the public good" by preventing informed decisions by doctors and patients. Read the complete study in Public Library of Science Medicine here.

TAGS: drugs, pharma, science, investigations

No comments: